The Cancer Research Institute Associate Board is a group of young leaders dedicated to advancing cancer immunotherapy research. Members lend professional expertise and diverse talents to develop social events, assist with fundraising initiatives, and cultivate individual and corporate relationships.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.